BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6352305)

  • 1. The anti-allergic effect of the beta 2-adrenergic agent fenoterol in the nose.
    Borum P; Mygind N; Larsen FS
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():44-9. PubMed ID: 6352305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D; Clement P; Smitz J; De Waele M
    Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-allergic effect of beta-2 agonists and cholinoceptor antagonists in vitro.
    Morr H
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():40-3. PubMed ID: 6193994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a beta-adrenergic agonist, fenoterol, on nasal sensitivity to allergen.
    Schumacher MJ
    J Allergy Clin Immunol; 1980 Jul; 66(1):33-6. PubMed ID: 6103906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the immediate allergic reaction in the nose by the beta-2 adrenostimulant fenoterol.
    Borum P; Mygind N
    J Allergy Clin Immunol; 1980 Jul; 66(1):25-32. PubMed ID: 7381123
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of intra-nasal fenoterol solution on perennial allergic rhinitis.
    Yan K; Shaw J
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():483-5. PubMed ID: 6352310
    [No Abstract]   [Full Text] [Related]  

  • 10. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal allergic rhinitis treated with a beta-2-adrenostimulant.
    Borum P; Larsen FS
    Allergy; 1987 Feb; 42(2):141-5. PubMed ID: 3035960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of beta-adrenergic substances on the allergic rhinitis (author's transl)].
    Jorde W; Bohlmann HG; Linsenmann P; Werdermann K
    Med Klin; 1975 Aug; 70(32-33):1314-6. PubMed ID: 1226155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ; Horak F; Nirnberger G; Rehn D
    Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
    Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
    Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beclomethasone dipropionate treatment on the nasal provocation test.
    Clement PA; Kaufman L
    Rhinology; 1984 Sep; 22(3):183-91. PubMed ID: 6505518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.